Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (281-290 of 939) with videos related to

Pageof 94
Sort By:
Oncotarget|January 8, 2016
Control of glioma cell migration and invasiveness by GDF-15Paula Codó, Michael Weller, Kerstin Kaulich, et al.
Neuro-Oncology|March 25, 2016
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivoEmese Szabo, Hannah Schneider, Katharina Seystahl, et al.
Journal of Neurochemistry|January 13, 2006
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cellsMirjam Hermisson, Andrea Klumpp, Wolfgang Wick, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell componentsMichel Mittelbronn, Jens Schittenhelm, Dieter Lemke, et al.
Journal of Neurochemistry|July 30, 2008
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XLJohannes Rieger, Dieter Lemke, Gabriele Maurer, et al.
Annals of Neurology|July 26, 2011
Current concepts and management of glioblastomaMatthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, et al.
Oncotarget|October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escapePaula Codo, Michael Weller, Gunter Meister, et al.
Journal of Neurology|September 15, 2019
Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patientsCarl Moritz Zipser, Jeremy Deuel, Jutta Ernst, et al.
Journal of Neurology|June 20, 2003
Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological diseaseUlrich Herrlinger, Frank Schwärzler, Robert Beck, et al.
Neuro-Oncology|December 25, 2010
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivoGünter Eisele, Patrick Roth, Kathy Hasenbach, et al.
Pageof 94

Showing results (281-290 of 939) with videos related to

Sort By:
Pageof 94
Oncotarget|January 8, 2016
Control of glioma cell migration and invasiveness by GDF-15Paula Codó, Michael Weller, Kerstin Kaulich, et al.
Neuro-Oncology|March 25, 2016
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivoEmese Szabo, Hannah Schneider, Katharina Seystahl, et al.
Journal of Neurochemistry|January 13, 2006
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cellsMirjam Hermisson, Andrea Klumpp, Wolfgang Wick, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell componentsMichel Mittelbronn, Jens Schittenhelm, Dieter Lemke, et al.
Journal of Neurochemistry|July 30, 2008
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XLJohannes Rieger, Dieter Lemke, Gabriele Maurer, et al.
Annals of Neurology|July 26, 2011
Current concepts and management of glioblastomaMatthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, et al.
Oncotarget|October 4, 2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escapePaula Codo, Michael Weller, Gunter Meister, et al.
Journal of Neurology|September 15, 2019
Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patientsCarl Moritz Zipser, Jeremy Deuel, Jutta Ernst, et al.
Journal of Neurology|June 20, 2003
Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological diseaseUlrich Herrlinger, Frank Schwärzler, Robert Beck, et al.
Neuro-Oncology|December 25, 2010
APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivoGünter Eisele, Patrick Roth, Kathy Hasenbach, et al.
Pageof 94